Concepedia

Rodwige Desnoyer

RD

Statistics

Publications

1

Citations

228

H-Index

1

Active since

2017

Affiliations

Stony Brook University(Current)

Rodwige Desnoyer is an author at Stony Brook University specializing in metastasis, chemotherapy, and toxicity risk assessment.

Publications per year

2017–2017

1

Publications

1

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial

Angela Alistar, Bonny Morris, Rodwige Desnoyer et al. · The Lancet Oncology · 2017 · 228 citations

Medicine, Oncology, Pharmacology +11

1–1 of 1